| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/28/2007 | US20070148089 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2007 | US20070148088 Cytotoxic therapy |
| 06/28/2007 | US20070148087 Tame based chelators and uses thereof |
| 06/28/2007 | DE102005063244A1 Modifiziertes 2-Nitroimidazol-Derivat The modified 2-nitroimidazole derivative |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | EP1799712A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 06/27/2007 | EP1799274A2 Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals |
| 06/27/2007 | EP1799273A2 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 06/27/2007 | EP1492570A4 Method of diagnosis and treatment of breast lesions |
| 06/27/2007 | EP1140873B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/27/2007 | EP0954340B1 Targeted combination immunotherapy of cancer |
| 06/27/2007 | CN1985997A Degradable radioactive sponge and its making process |
| 06/27/2007 | CN1323082C Indicated tetraodotoxin, preparation and use thereof |
| 06/26/2007 | CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 06/21/2007 | WO2007070115A1 Luminescent metallic cluster particles and uses thereof |
| 06/21/2007 | WO2007001466A3 Peptidomimetic somatostatin receptor subtype 2 ligands and pet imaging agents |
| 06/21/2007 | WO2006120230A3 Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | US20070142398 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142340 Steroids as agonists for FXR |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070141659 Sets and Compositions Pertaining to Analyte Determination |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141351 Preparing aqueous mixture of continuous water-soluble polymer phase and discontinuous chromonic phase to form chromonic nanoparticles, crosslinking particles with multivalent cation, dispersing, encapsulating particles in second water-soluble polymer phase and chromonic phase comprising guest compound |
| 06/21/2007 | US20070141025 Compositions and methods for cancer immunotherapy |
| 06/21/2007 | US20070140970 Cell targeting conjugates |
| 06/21/2007 | US20070140967 Agents and methods for analyzing protein interactions |
| 06/21/2007 | US20070140966 Multivalent immunoglobulin-based bioactive assemblies |
| 06/21/2007 | US20070140965 Methods to ameliorate and image angioplasty-induced vascular injury |
| 06/21/2007 | US20070140964 Cytokine receptor zcytor17 multimers |
| 06/21/2007 | US20070140963 Cytokine receptor zcytor17 multimers |
| 06/21/2007 | US20070140962 Light Sensitive Compounds for Instant Determination of Organ Function |
| 06/21/2007 | US20070140961 Radiotherapeutic high specific activity tin-117m and methods of use |
| 06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
| 06/21/2007 | US20070140959 Method of preparing rhenium-tricarbonyl complex and its precursor |
| 06/21/2007 | US20070140958 Rubidium generator for cardiac perfusion imaging and method of making and maintaining same |
| 06/21/2007 | US20070140957 Hierarchical chromonic structures |
| 06/20/2007 | EP1797904A1 Method of preparing rhenium-188 tricarbonyl triaqua complex |
| 06/20/2007 | EP1796738A2 Diagnostic compounds for targeting a chemokine receptor |
| 06/20/2007 | EP1796737A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof |
| 06/20/2007 | EP1796736A2 Metalloproteinase inhibitor imaging agents |
| 06/20/2007 | EP1796735A2 Immunotherapy of autoimmune disorders |
| 06/20/2007 | EP1796733A2 Urokinase plasminogen activator receptor targeted contrast agents |
| 06/20/2007 | EP1796721A1 Cancerous disease modifying antibodies |
| 06/20/2007 | CN1322517C Radioactive liquid generating system and heating chamber with dispensing function |
| 06/19/2007 | US7232559 Diagnostic agents for pancreatic exocrine function |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/14/2007 | WO2007066567A1 Process for production of compound labeled with radioactive fluorine |
| 06/14/2007 | WO2007034210A3 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 06/14/2007 | WO2006078629A3 In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair |
| 06/14/2007 | WO2006030291A3 Radiofluorinated peptides |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134197 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 06/14/2007 | US20070134155 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II |
| 06/14/2007 | US20070134154 Tumor-Targeted nanodelivery systems to improve early MRI detection of cancer |
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/14/2007 | CA2632133A1 Process for production of compound labeled with radioactive fluorine |
| 06/13/2007 | EP1795208A1 Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure |
| 06/13/2007 | EP1793832A2 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/13/2007 | EP1311303B1 Novel radiotherapeutic formulations containing 224 ra and a method for their production |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | CN1981029A Cholesterol-producing yeast strains and uses thereof. |
| 06/13/2007 | CN1980940A Isotopically-enriched boranes and methods of preparing them |
| 06/13/2007 | CN1977999A Method for selectively killing cells utilizing ultraviolet conversion luminous nano particles |
| 06/13/2007 | CN1321127C Iodine (I)-23-hydroxyl betulinic acid, rpeparation method and application thereof |
| 06/12/2007 | US7230085 Anti-DOTA antibody |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7229620 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer |
| 06/12/2007 | US7229606 Diagnostic imaging contrast agents with extended blood retention |
| 06/12/2007 | US7229604 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 06/12/2007 | US7229603 Stablilized and lyophilized radiopharmaceutical agents |
| 06/12/2007 | CA2249410C Sigma-2 receptors as biomarkers of tumor cell proliferation |
| 06/07/2007 | WO2007064906A2 Devices and methods for endoluminal gastric restriction and tissue manipulation |
| 06/07/2007 | WO2007064800A2 Methods to ameliorate and image angioplasty-induced vascular injury |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007063940A1 Process for production of compound labeled with radioactive fluorine |
| 06/07/2007 | WO2007062855A2 Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma |
| 06/07/2007 | WO2007038626A3 Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging |
| 06/07/2007 | WO2007001940A3 Imaging agents |
| 06/07/2007 | WO2005016234A3 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |
| 06/07/2007 | US20070129382 Crf receptor antagonists, their preparations, their pharmaceutical composition, and their uses |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128119 Pendant fatty acid imaging agents |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | US20070128111 Immunoglobulin for use in treatment and prevention of immunological and cancer disorders; immunotherapy; antibodies with modified hinge cysteine residues |
| 06/07/2007 | US20070128110 Stereoisomers of fatty acid analogs for diagnostic imaging |
| 06/07/2007 | US20070128109 Stabilized and lyophilized radiopharmaceutical agents for destroying tumors |
| 06/07/2007 | US20070128108 Therapy of malignant neoplasias |
| 06/07/2007 | US20070128107 administering and determining specific binding of radiolabelled (+)-4-propyl-9-hydroxy-2,3,4a,5,6,10b-hexahydro-4H-naphth[1,2b][1,4]-oxazine hydrochloride salts in human brains, by tomography; diagnosis of psychological disorders |
| 06/07/2007 | CA2657452A1 Immunoconjugate for human cd66 for the treatment of multiple myeloma and other haematological malignancies |
| 06/07/2007 | CA2632553A1 Process for production of compound labeled with radioactive fluorine |
| 06/07/2007 | CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 06/06/2007 | EP1791571A2 Radiofluorinated peptides |
| 06/06/2007 | EP1791553A2 Compositions for delivering peptide yy and pyy agonists |
| 06/06/2007 | EP1333866A4 Polymer based radionuclide containing particulate material |
| 06/06/2007 | EP1333865A4 Inorganic low density radionuclide coated particles |
| 06/06/2007 | EP1333864A4 Low density radionuclide-containing particulate material |
| 06/06/2007 | CN1976728A Contrast agents for myocardial perfusion imaging. |